Tags: market
April 5, 2024
You may also like
Aurobindo Pharma | USFDA Approval– Aurobindo Pharma Limited has received final approval from the USFDA to manufacture and market their version of Mometasone Furoate Monohydrate Nasal Spray, which is equivalent to Nasonex Nasal Spray. – This new product will be launched in the first quarter of fiscal year 2025, potentially opening up new revenue streams for the company
Aurobindo Pharma | USFDA Approval – Aurobindo Pharma Limited has received final approval from the USFDA to manufacture and market...
MAX ESTATES: CO SECURES NOIDA APPROVAL FOR “DELHI ONE” COMMERCIAL PROJECT, PROCEEDS WITH NCLAT RATIFICATION FOR RESOLUTION PLAN IMPLEMENTATION #Investment #StockMarket #FinancialNews #TradingGlobal MAX ESTATES: CO SECURES NOIDA APPROVAL FOR “DELHI ONE” COMMERCIAL PROJECT, PROCEEDS WITH NCLAT RATIFICATION FOR RESOLUTION PLAN IMPLEMENTATION #Investment #StockMarket #FinancialNews #TradingGlobal
MAX ESTATES: CO SECURES NOIDA APPROVAL FOR "DELHI ONE" COMMERCIAL PROJECT, PROCEEDS WITH NCLAT RATIFICATION FOR RESOLUTION PLAN IMPLEMENTATION #Investment...
Comments are closed.